Back to Results
First PageMeta Content



Phase 2 Clinical Data of SEL-212 in Symptomatic Gout Patients: Monthly Dosing of a Pegylated Uricase (Pegsiticase) with SVPRapamycin Enables Sustained Reduction of Serum Uric Acid Levels by Mitigating Formation of Anti-D
Add to Reading List

Document Date: 2018-04-10 18:00:06

Open Document

File Size: 1,35 MB

Share Result on Facebook
UPDATE